Navigation Links
Study uncovers why anti-rejection drugs for transplant patients cause hypertension
Date:10/7/2011

PORTLAND, Ore. Modern medicine's ability to save lives through organ transplantation has been revolutionized by the development of drugs that prevent the human body from rejecting the transplanted organ.

But those antirejection drugs have their own side effects sometimes serious.

A group of researchers led by scientists at Oregon Health & Science University has discovered the process that may be causing many of those side effects. And the discovery means those side effects likely can be dealt with cheaply and easily with a class of widely used drugs that are often avoided in patients with organ transplants.

The researchers' findings were published this week in the online edition of the journal Nature Medicine.

The researchers examined the effects of a class of antirejection or immunosuppressive drugs called calcineurin inhibitors, which includes cyclosporine and tacrolimus.

Calcineurin inhibitors, which can be instrumental in preventing organ rejection in transplant patients, also can cause hypertension and kidney problems. The researchers' findings reveal what ultimately causes those problems a calcineurin inhibitor spurs the production of an abnormally high level of a natural protein in the kidney.

Researchers found that a thiazide diuretic drug, which blocks the responsible protein, reduced hypertension in mice that had been given the calcineurin inhibitor. And mice lacking this protein did not develop hypertension at all.

The collaborative team of researchers, which included scientists from University College London, extended their observations to humans kidney transplant patients in the United Kingdom.

University College London scientists found that kidney transplant patients who received the calcineurin inhibitor were more sensitive to a thiazide diuretic than were patients treated with other antirejection drugs.

The research results could mean very good new
'/>"/>

Contact: Todd Murphy
murphyt@ohsu.edu
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study finds liver cancer increasing in low risk countries, decreasing in high risk countries
2. Oxygenating Blood of Hospitalized H1N1 Flu Patients Saved Lives: Study
3. National Study Will Track Tobacco Use in U.S.
4. Many Medicare Patients Get Surgeries in Last Year of Life: Study
5. FDA and NIH announce joint study on tobacco use and risk perceptions
6. MRI Safe With More Recent Defibrillators, Pacemakers: Study
7. Nursing Homes Not Meeting Flu-Shot Goals, Study Says
8. Virginia Commonwealth University study: We are what we experience
9. New study shows inflammatory food toxins found in high levels in infants
10. Wayne State University to study effects of risky family environments on childhood asthma
11. Overnight Stay May Not Be Necessary for Stenting: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... WHAT: , A mathematical model developed by NIH grantees ... daily to prevent HIV infection via vaginal sex, whereas ... HIV infection via anal sex. This finding helps explain ... or PrEP, in women failed to show efficacy. Participants ... trials of Truvada and tenofovir (another antiretroviral) for HIV ...
(Date:10/30/2014)... San Diego, Calif. (PRWEB) October 30, 2014 ... no longer mutually exclusive concepts in the medical-grade ... focusing on the development of uniquely potent topical ... Skin Health System ( http://www.RefinitySkinScience.com ) with patented ... highest available glycolic acid concentrations (50% and 70%) ...
(Date:10/30/2014)... By Steven Reinberg ... -- Giving hormone therapy to men with prostate cancer who ... dying from a heart-related cause, a new study suggests. , , ... It,s used in prostate cancer to reduce levels of male ... the study. And, in the current research, this hormone therapy ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Horse ... therapeutic horseback riding to special needs individuals in the ... on Saturday, November 15 from 10-2:00 p.m. at Bailey's ... is open to the public and is designed to ... , Admission to the HSS Round-Up is free. Ticket ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
Breaking Medicine News(10 mins):Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3
... , , Cuts Will ... to Recent Cuts , , ... Chairman Max Baucus (D-Mont.) issued his recommendations for healthcare reform in ... bill contains several provisions that affect home medical equipment, ranging from ...
... remain unknown, expert says, , WEDNESDAY, Sept. 16 (HealthDay News) ... for older women: stopping hot flashes. , In a ... the New England Journal of Medicine , researchers from ... cetrorelix (Cetrotide) helped ease hot flash symptoms. , "It ...
... obesity, but beverage industry balks at proposal , WEDNESDAY, Sept. ... per ounce of soda and other sugary drinks could stem ... first year alone, health experts say. , That windfall could ... to prevent obesity, say a group of prominent researchers in ...
... , NEW YORK, Sept. 16 As ... If the thought of skinny jeans has you feeling uneasy, think ... you into those new jeans. , , Listen ... , , Registered journalists can access video, audio, ...
... , , MINNEAPOLIS, Sept. 16 ... Board Members and thanked outgoing members for their service to the ... was elected as the new Board Chair. The full roster of ... David Fisher, Board Chair - ...
... , THE GLOBALIZATION PLATFORM ... More than 120 delegates, including heads of state, acclaimed artists, Nobel ... City for the fourth annual Global Creative Leadership Summit , ... globalization. Organized by the Louise Blouin Foundation , an international ...
Cached Medicine News:Health News:Senate Finance Committee Cuts Home Medical Equipment in Reform Package 2Health News:Fertility Drug Shows Potential Against Hot Flashes 2Health News:Fertility Drug Shows Potential Against Hot Flashes 3Health News:'Soda Tax' Wins Health Experts' Support 2Health News:'Soda Tax' Wins Health Experts' Support 3Health News:'Soda Tax' Wins Health Experts' Support 4Health News:ClearWay Minnesota(SM) Board Approves New Officers 2Health News:Global Creative Leadership Summit 23-25 September 2009 2Health News:Global Creative Leadership Summit 23-25 September 2009 3
(Date:10/30/2014)... YORK , Oct. 30, 2014  The number ... States is growing steadily, thanks to drug ... as a result of the economic downturn, retail clinic ... a year of opportunities, as the number of retail ... researcher,s report, Retail Clinics Market Overview and 2014 ...
(Date:10/30/2014)... Molecular Profiles Ltd., a subsidiary of Columbia ... Maryland -based Xceleron have announced a collaboration ... development that will be launched at AAPS in ... This partnership extends Molecular Profiles, new ROADMAP to Clinical ... month. The company also has complementary collaborations in place ...
(Date:10/30/2014)... LOS ANGELES , Oct. 30, 2014 /PRNewswire/ ... biopharmaceutical research and development company specializing in oncology, ... technology and its lead drug candidate, aldoxorubicin.  The ... A New Approach," will be given by ... the Sarcoma Oncology Center and principal investigator of ...
Breaking Medicine Technology:Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4
... AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR ) ... for the quarter ended December 31, 2010 before market ... and Chief Executive Officer, Randall Kaye, M.D., Senior Vice ... President, Finance, will host an investment community conference call ...
... 27, 2011 Higher volume drove four ... in Q4 led to growth in operating income. ... (non-GAAP). Full-year 2010 revenue topped $23 billion as ... exceed $1 billion in annual sales. Full-year 2010 ...
Cached Medicine Technology:Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 2Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 3Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 4Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 5Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 6Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 7Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 8Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 9Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 10Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 11Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 12Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 13Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 14Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 15Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 16Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 17Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 18Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 19Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 20Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 21
... rotary retracting, self-lubricating design and has a heavy ... construction makes it accurate and incredibly reliable. ,The ... lateral motion is controlled and allows no slop ... lesser designs which can result in 'chatter' and ...
... The new SureCut M3500 Radial Microtome has ... is marvelous, and a range of functions and ... users. Based on years of experience and ... innovative design the SureCut M3500 Microtome will be ...
This is an economical (portable) microtome designed for fast and accurate sectioning. The specimen rise is automatic and accurate with each handle movement. Section thickness from 5 to 40 microns. ...
Honing compound for knife sharpening, 6 grams net...
Medicine Products: